Clinical trials
Completed Vision Disorders trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Bayer | 1 |
| PD Dr. med. Katja Hatz | 1 |
| University of Lausanne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vision Disorders | 9 |
| Choroidal Neovascularization | 4 |
| Macular Degeneration | 4 |
| Eye Diseases | 3 |
| Geographic Atrophy | 3 |
| Retinal Diseases | 3 |
| Wet Macular Degeneration | 3 |
| Macular Edema | 2 |
| Retinal Degeneration | 2 |
| Blindness | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.